Alberta Spirits culture and Calgary Stampede: Alberta has higher spirits consumption than other provinces
End User Insights Which End User Segment Led the GLP-1 Market
The American Association of Clinical Endocrinology now recommends considering long-term pharmacotherapy for obesity management
These products do not contain GLP-1, do not act like prescription drugs, and are not proven to help you lose weight in a meaningful or reliable way
The appetite feedback coefficient for tirzepatide (k=48) is marginally lower than semaglutide (k=49), which means the appetite rebound component may be very slightly less aggressive, potentially contributing to a somewhat longer active loss phase in some individuals
GLP-1s are not safe for people with a history of pancreatitis, certain thyroid cancers, MEN2 syndrome, severe kidney/liver disease, or during pregnancy/breastfeeding. How are GLP-1 medications taken